JP2005506151A - ステント - Google Patents

ステント Download PDF

Info

Publication number
JP2005506151A
JP2005506151A JP2003537695A JP2003537695A JP2005506151A JP 2005506151 A JP2005506151 A JP 2005506151A JP 2003537695 A JP2003537695 A JP 2003537695A JP 2003537695 A JP2003537695 A JP 2003537695A JP 2005506151 A JP2005506151 A JP 2005506151A
Authority
JP
Japan
Prior art keywords
stent
group
formula
compound
restenosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003537695A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005506151A5 (enExample
Inventor
エリーザベト・ペルツボルン
ヨッヘン・カルベ
ヴォルフラム・レトヴォッホ
ディディエ・ムーリアン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of JP2005506151A publication Critical patent/JP2005506151A/ja
Publication of JP2005506151A5 publication Critical patent/JP2005506151A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/04—Use of organic materials, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2003537695A 2001-10-24 2002-10-11 ステント Pending JP2005506151A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10152460A DE10152460A1 (de) 2001-10-24 2001-10-24 Stents
PCT/EP2002/011402 WO2003035133A1 (de) 2001-10-24 2002-10-11 Stents

Publications (2)

Publication Number Publication Date
JP2005506151A true JP2005506151A (ja) 2005-03-03
JP2005506151A5 JP2005506151A5 (enExample) 2006-01-05

Family

ID=7703557

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003537695A Pending JP2005506151A (ja) 2001-10-24 2002-10-11 ステント

Country Status (22)

Country Link
US (1) US20050064006A1 (enExample)
EP (1) EP1439869A1 (enExample)
JP (1) JP2005506151A (enExample)
KR (1) KR20040074977A (enExample)
CN (1) CN1575189A (enExample)
AU (1) AU2002340549B2 (enExample)
BR (1) BR0213481A (enExample)
CA (1) CA2464290A1 (enExample)
DE (1) DE10152460A1 (enExample)
EC (1) ECSP045075A (enExample)
EE (1) EE200400080A (enExample)
HR (1) HRP20040456A2 (enExample)
HU (1) HUP0401760A3 (enExample)
IL (1) IL161445A0 (enExample)
MA (1) MA26341A1 (enExample)
MX (1) MXPA04003755A (enExample)
NO (1) NO20041984L (enExample)
NZ (1) NZ532443A (enExample)
PL (1) PL367968A1 (enExample)
RU (1) RU2004115757A (enExample)
WO (1) WO2003035133A1 (enExample)
ZA (1) ZA200402989B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023527328A (ja) * 2020-05-26 2023-06-28 エリクシアー メディカル コーポレイション 抗凝固化合物ならびにその使用のための方法およびデバイス

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) * 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) * 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
NZ567092A (en) 2005-10-04 2011-05-27 Bayer Schering Pharma Ag Novel polymorphous form and the amorphous form of 5-chloro-N-({ (5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
US20070097252A1 (en) * 2005-10-31 2007-05-03 Silverstein D A Imaging methods, cameras, projectors, and articles of manufacture
DE102006034916A1 (de) * 2006-07-28 2008-01-31 Bayer Healthcare Ag Beschichtung künstlicher Oberflächen von medizinischen Hilfsmitteln und Geräten sowie Reinigung und/oder Vorbehandlung von Kathetern und anderen medizinischen Hilfsmitteln und Geräten
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
US8741890B2 (en) 2007-11-15 2014-06-03 Boehringer Ingelheim International Gmbh Substituted amides, manufacturing and use thereof as medicaments
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE181735T1 (de) * 1993-05-01 1999-07-15 Merck Patent Gmbh Substituierte 1-phenyl-oxazolidin-2-on derivate, deren herstellung und deren verwendung als adhäsionsrezeptor-antagonisten
CA2285705A1 (en) * 1997-04-14 1998-10-22 Cor Therapeutics, Inc. Selective factor xa inhibitors
US6273913B1 (en) * 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US20010029351A1 (en) * 1998-04-16 2001-10-11 Robert Falotico Drug combinations and delivery devices for the prevention and treatment of vascular disease
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10105989A1 (de) * 2001-02-09 2002-08-14 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023527328A (ja) * 2020-05-26 2023-06-28 エリクシアー メディカル コーポレイション 抗凝固化合物ならびにその使用のための方法およびデバイス

Also Published As

Publication number Publication date
NZ532443A (en) 2005-11-25
MXPA04003755A (es) 2004-07-23
ECSP045075A (es) 2004-05-28
CA2464290A1 (en) 2003-05-01
MA26341A1 (fr) 2004-10-01
HRP20040456A2 (en) 2005-06-30
US20050064006A1 (en) 2005-03-24
AU2002340549B2 (en) 2007-11-29
HUP0401760A2 (hu) 2004-12-28
ZA200402989B (en) 2005-04-20
RU2004115757A (ru) 2005-04-10
DE10152460A1 (de) 2003-05-08
WO2003035133A1 (de) 2003-05-01
KR20040074977A (ko) 2004-08-26
NO20041984L (no) 2004-05-13
BR0213481A (pt) 2004-11-03
EP1439869A1 (de) 2004-07-28
PL367968A1 (en) 2005-03-07
EE200400080A (et) 2004-08-16
HUP0401760A3 (en) 2008-04-28
CN1575189A (zh) 2005-02-02
IL161445A0 (en) 2004-09-27

Similar Documents

Publication Publication Date Title
JP2005506151A (ja) ステント
JP5368991B2 (ja) 薬剤徐放性ステント
JP4473390B2 (ja) ステント及びステントグラフト
JP4757448B2 (ja) 医療用装置塗布方法
ES2249576T3 (es) Aporte de medicamento desde stents.
ES2272896T3 (es) Dispositivos medicos revestidos para el tratamiento de una enfermedad vascular.
KR101682362B1 (ko) 라파마이신 저장기 용출 스텐트
WO2009144580A2 (en) Coatings for promoting endothelization of medical devices
JP2005523045A (ja) 持効性の薬剤送出系を被覆したステント及びその使用方法
MXPA04008361A (es) Stents recubiertos con n-{5 -[4-(4- metil-piperazino- metil)- benozilamido]- 2-metilfenil} -4-(3- piridil) -2- pirimidin- amina.
JP5774284B2 (ja) 二薬ステント
US20120130480A1 (en) Local vascular delivery of adenosine a2a receptor agonists to reduce myocardial injury
US20050175667A1 (en) Use of endothelin antagonists to prevent restenosis
AU2005229566A1 (en) VEGF receptor tyrosine kinase inhibitor coated stent
AU2011329270B2 (en) Local vascular delivery of an adenosine A2A receptor agonist / phosphodiesterase inhibitor combination to reduce myocardial injury
HK1073803A (en) Stents
WO2005063251A1 (en) Modified stent useful for delivery of drugs along stent strut
JP2004534618A (ja) 再狭窄に対するビトロネクチン受容体アンタゴニストを有するステント
MXPA06011234A (es) Stent recubierto con tirosina cinasa de receptor de vegf

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051006

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051006

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090519

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091201